Trial Profile
Cross-over multiple dose study assessing the analgesic efficacy and safety of oral GRT9906 PR compared to active comparator and placebo in subjects with painful polyneuropathy of mixed origin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2018
Price :
$35
*
At a glance
- Drugs GRT 9906 (Primary) ; Tramadol
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Grunenthal
- 19 Dec 2011 Primary endpoint 'Numerical-Rating-Scale' has been met.
- 05 Nov 2010 New trial record.